GENERATION BIO CO. - COMMON STOCK

Generation Bio Presents Preclinical Data Demonstrating Broad Potential of Gene Therapy Platform at ASGCT and Reports First Quarter Financial Results

12 May 2021 16:20:00 By Nasdaq GlobeNewswire

Generation Bio to Present at American Society of Gene & Cell Therapy 2021 Virtual Annual Meeting

27 Apr 2021 16:35:00 By Nasdaq GlobeNewswire

Generation Bio to Present at 20th Annual Needham Virtual Healthcare Conference

08 Apr 2021 07:30:00 By Nasdaq GlobeNewswire

Generation Bio Reports Fourth Quarter and Full Year 2020 Financial Results

18 Mar 2021 08:00:01 By Nasdaq GlobeNewswire

Generation Bio Appoints Ron Cooper to Its Board of Directors

18 Feb 2021 07:30:00 By Nasdaq GlobeNewswire

Generation Bio Announces Closing of Public Offering

11 Jan 2021 17:43:32 By Nasdaq GlobeNewswire

Generation Bio Announces Pricing of Public Offering

06 Jan 2021 21:23:59 By Nasdaq GlobeNewswire

Generation Bio to Present at 39th Annual J.P. Morgan Healthcare Conference

05 Jan 2021 06:30:00 By Nasdaq GlobeNewswire

Generation Bio Announces Two Non-Viral Gene Therapy Milestone Achievements: Target Levels of Factor VIII Expression in Hemophilia A Mice and Translation of Expression from Mice to Non-Human Primates

04 Jan 2021 06:30:00 By Nasdaq GlobeNewswire